Colgate-Palmolive's 15-minute chart has recently exhibited a MACD Death Cross and a KDJ Death Cross, which occurred on October 6, 2022 at 11:15. This suggests that the stock price has the potential to continue its downward trajectory, as the momentum of the stock price is shifting towards the downside and may further decrease.
Colgate-Palmolive Company (NYSE: CL) has recently experienced a significant technical indicator shift, which could signal a downward trend in its stock price. On October 6, 2022, at 11:15, the 15-minute chart exhibited a MACD Death Cross and a KDJ Death Cross. These indicators suggest that the momentum of the stock price is shifting towards the downside, potentially leading to further declines in the stock's value.
The MACD (Moving Average Convergence Divergence) is a technical indicator that shows the relationship between two moving averages of a stock's price. A MACD Death Cross occurs when the MACD line crosses below the signal line, indicating a potential reversal in the stock's price trend. Similarly, the KDJ (K Moving Average, D Moving Average, J Stochastic) indicator is used to measure momentum and trend strength. A KDJ Death Cross occurs when the K line crosses below the D line, also indicating a potential reversal in the stock's momentum.
These technical signals come amidst a period of mixed analyst sentiment. While some analysts have maintained a "buy" rating, others have adjusted their price targets downward. For instance, Goldman Sachs reduced its price target from $106 to $91, while maintaining a "buy" rating
Colgate-Palmolive Company $CL Shares Sold by Truist Financial Corp[1]. Other analysts, such as Wells Fargo & Company, have set an "underweight" rating with a price target of $80
Colgate-Palmolive Company $CL Shares Sold by Truist Financial Corp[1].
Colgate-Palmolive reported strong earnings for the quarter ending August 1, 2022, with earnings per share (EPS) of $0.92, exceeding the estimated $0.89
Boston Common Asset Management LLC Has $27.50 Million Stock Holdings in Colgate-Palmolive Company $CL[2]. The company also announced a quarterly dividend of $0.52 per share, yielding 2.7%
Boston Common Asset Management LLC Has $27.50 Million Stock Holdings in Colgate-Palmolive Company $CL[2]. Despite these positive fundamentals, the recent technical indicators suggest caution for investors.
Institutional investors have also been adjusting their holdings in Colgate-Palmolive. Truist Financial Corp reduced its holdings by 3.7% in the second quarter, while other institutional investors like Boston Common Asset Management LLC and Autumn Glory Partners LLC increased their holdings
Colgate-Palmolive Company $CL Shares Sold by Truist Financial Corp[1]Boston Common Asset Management LLC Has $27.50 Million Stock Holdings in Colgate-Palmolive Company $CL[2]. However, the overall sentiment among institutional investors remains bullish, with them owning 80.41% of the company's stock
Colgate-Palmolive Company $CL Shares Sold by Truist Financial Corp[1]Boston Common Asset Management LLC Has $27.50 Million Stock Holdings in Colgate-Palmolive Company $CL[2].
Given the recent technical indicators and mixed analyst sentiment, investors may want to exercise caution when considering Colgate-Palmolive. While the company's fundamentals remain strong, the technical signals suggest a potential downward trend in the stock's price.
Comments
No comments yet